Author： Martyn Christopher N Hall Nigel F
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.7, 2002-07, pp. : 803-807
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Burden of Age-Related Macular Degeneration
By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.
PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. :
Access to resources
Recommend
Pegaptanib: In Exudative Age-Related Macular Degeneration
By Siddiqui M. Asif A. Keating Gillian M.
Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. :
Age-Related Macular Degeneration: Epidemiology and Optimal Treatment
By Lacour M.
Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. :
Prospective therapeutics for age-related macular degeneration
By Chiesa R.
Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. :